These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 16127593)
1. An open multicenter study of the use of gatifloxacin for the treatment of non-complicated acute bacterial rhinosinusitis in adults. Weckx LL; Campos CA; Sakano E; Pignatari SS; Figueiredo CR Braz J Infect Dis; 2005 Apr; 9(2):162-8. PubMed ID: 16127593 [TBL] [Abstract][Full Text] [Related]
2. Community-based treatment of acute uncomplicated bacterial rhinosinusitis with gatifloxacin. Sher LD; Poole MD; Von Seggern K; Wikler MA; Nicholson SC; Pankey GA Otolaryngol Head Neck Surg; 2002 Sep; 127(3):182-9. PubMed ID: 12297808 [TBL] [Abstract][Full Text] [Related]
3. A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis. Sher LD; McAdoo MA; Bettis RB; Turner MA; Li NF; Pierce PF Clin Ther; 2002 Feb; 24(2):269-81. PubMed ID: 11911557 [TBL] [Abstract][Full Text] [Related]
4. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration. Lopez Sisniega J; Profant M; Kostrica R; Waskin H Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545 [TBL] [Abstract][Full Text] [Related]
5. Current management of acute bacterial rhinosinusitis and the role of moxifloxacin. Anon JB Clin Infect Dis; 2005 Jul; 41 Suppl 2(Suppl 2):S167-76. PubMed ID: 15942883 [TBL] [Abstract][Full Text] [Related]
6. Bacteriologic and clinical efficacy of oral gatifloxacin for the treatment of recurrent/nonresponsive acute otitis media: an open label, noncomparative, double tympanocentesis study. Leibovitz E; Piglansky L; Raiz S; Greenberg D; Hamed KA; Ledeine JM; Press J; Leiberman A; Echols RM; Pierce PF; Jacobs MR; Dagan R Pediatr Infect Dis J; 2003 Nov; 22(11):943-9. PubMed ID: 14614364 [TBL] [Abstract][Full Text] [Related]
7. An open label, multicenter, non-comparative study of the efficacy and safety of oral gatifloxacin in the treatment of community-acquired pneumonia: a Brazilian study in five centers. Nicodemo AC Braz J Infect Dis; 2003 Feb; 7(1):62-8. PubMed ID: 12807692 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of gatifloxacin in community treatment of acute exacerbations of chronic bronchitis. Anzueto A; Gotfried M; Wikler MA; Russo R; Nicholson SC Clin Ther; 2002 Jun; 24(6):906-17. PubMed ID: 12117081 [TBL] [Abstract][Full Text] [Related]
9. Gatifloxacin phase IV surveillance trial (TeqCES study) utilizing 5000 primary care physician practices: report of pathogens isolated and susceptibility patterns in community-acquired respiratory tract infections. Pfaller MA; Jones RN Diagn Microbiol Infect Dis; 2002 Sep; 44(1):77-84. PubMed ID: 12376036 [TBL] [Abstract][Full Text] [Related]
10. Herbal Drug EPs 7630 Perić A; Gaćeša D; Barać A; Sotirović J; Perić AV Ann Otol Rhinol Laryngol; 2020 Oct; 129(10):969-976. PubMed ID: 32456442 [TBL] [Abstract][Full Text] [Related]
12. A Surveillance Bacteriological Study of Acute Bacterial Rhinosinusitis in Thailand and the Clinical Responses to the Culture-directed Antibiotics. Thanaviratananich S; Chusakul S; Moungthong G; Luxameechanporn T; Tantilipikorn P; Fooanant S; Aeumjaturapat S; Sribenjalux P; Makachen N; Chainansamit S; Chaiyasate S; Bunnag C J Med Assoc Thai; 2015 Aug; 98 Suppl 7():S204-16. PubMed ID: 26742392 [TBL] [Abstract][Full Text] [Related]
13. Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults. Sydnor TA; Kopp EJ; Anthony KE; LoCoco JM; Kim SS; Fowler CL Ann Allergy Asthma Immunol; 1998 Apr; 80(4):357-62. PubMed ID: 9564988 [TBL] [Abstract][Full Text] [Related]
14. Open label, multicenter study of gatifloxacin treatment of recurrent otitis media and acute otitis media treatment failure. Arguedas A; Sher L; Lopez E; Sáez-Llorens X; Hamed K; Skuba K; Pierce PF Pediatr Infect Dis J; 2003 Nov; 22(11):949-56. PubMed ID: 14614365 [TBL] [Abstract][Full Text] [Related]
15. Treatment of rhinosinusitis in the outpatient setting. Poole MD; Portugal LG Am J Med; 2005 Jul; 118 Suppl 7A():45S-50S. PubMed ID: 15993677 [TBL] [Abstract][Full Text] [Related]
16. High prevalence of antibiotic resistance in isolates from the middle meatus of children and adults with acute rhinosinusitis. Huang WH; Fang SY Am J Rhinol; 2004; 18(6):387-91. PubMed ID: 15706987 [TBL] [Abstract][Full Text] [Related]
17. Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children. Sher L; Arguedas A; Husseman M; Pichichero M; Hamed KA; Biswas D; Pierce P; Echols R Pediatr Infect Dis J; 2005 Apr; 24(4):301-8. PubMed ID: 15818288 [TBL] [Abstract][Full Text] [Related]
18. Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumonia. Lode H; Magyar P; Muir JF; Loos U; Kleutgens K; Clin Microbiol Infect; 2004 Jun; 10(6):512-20. PubMed ID: 15191378 [TBL] [Abstract][Full Text] [Related]
19. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial. Marple BF; Roberts CS; de Caprariis PJ; Reisman A Clin Ther; 2007 Dec; 29(12):2690-8. PubMed ID: 18201585 [TBL] [Abstract][Full Text] [Related]